The low-dose ACTH test in the ICU: Not ready for prime time
Arthur J. Boujoukos · Critical Care · 2006
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Critical Care · BioMed Central · book-review · 2006
Abstract
Expanded AbstractCitationSiraux V, De Backer D, Yalavatti G, Melot C, Gervy C, Mockel J, Vincent JL: Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests.
Crit Care Med 2005, 33:2479–2486 [1].ObjectiveTo compare a low-dose (1 μg) adrenocorticotropic hormone (ACTH) stimulation test with the more standard (250 μg) test for the diagnosis of relative adrenal insufficiency.MethodsDesign and settingDiagnostic study in a thirty-one bed mixed medico-surgical department of intensive carePatientsForty-six consecutive patients with septic shock.InterventionCorticotropin stimulation tests (low-dose test, 1 μg, and standard 250-μg test), performed consecutively at an interval >4 hrs.Measurements and main resultsIn each test, serum cortisol levels were measured before (T0) and 30 (T30), 60 (T60), and 90 (T90) mins after corticotropin injection.
The maximal increase in cortisol (max) was calculated as the difference between T0 and the highest cortisol value at T30, T60, or T90 and considered as adequate if >9 μg/dL (250 nmol/L). Nonresponders to the low dose test had a lower survival rate than responders to both tests (27 vs. 47%, p = .06; Kaplan Meier curves). Interestingly, nonresponders to high-dose test received hydrocortisone treatment and had a similar survival to responders.
Multivariable logistic regression disclosed that the response to the combined low-dose test and high-dose test was an independent predictor of survival (odds ratio 28.91, 95% confidence interval 1.81–462.70, p = .017), whereas basal or maximal cortisol levels in both tests were not.ConclusionThe low-dose test identified a subgroup of patients in septic shock with inadequate adrenal reserve who had a worse outcome and would have been missed by the high-dose test. These patients may also benefit from glucocorticoid replacement therapy.
Open the resolved locator · 10.1186/cc5000
Metadata licence: OpenAlex metadata (CC0)